Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01494896 · ClinicalTrials.gov registry record
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 9
- Enrollment target
NCT01494896: Clinical Trial study, sponsored by University of Florida.
NCT01494896 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01494896 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to see how inhaled treprostinil sodium (Tyvaso) affects the amount of air and blood that reach the alveoli, or tiy air sacs, in the lungs of patients with Group 1 Pulmonary Arterial Hypertension with concomitant Chronic Obstructive Pulmonary Disease (COPD).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-12 |
Why NCT01494896 stopped before completion
NCT01494896 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01494896 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01494896 about?
NCT01494896 is a clinical study titled "Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching". The purpose of this study is to see how inhaled treprostinil sodium (Tyvaso) affects the amount of air and blood that reach the alveoli, or tiy air sacs, in the lungs of patients with Group 1 Pulmonary Arterial Hypertension with concomitant Chronic Obstructive Pulmonary Disease (COPD).
What is the current status of trial NCT01494896?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2011-11. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01494896?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia